In the cIMPACT-NOW Consortiun for taxonomy of primary brain tumors suggested to reclassify those patients who had IDH wild-type diffuse gliomas as diffuse astrocytic gliomas, IDH wild-type with molecular features of glioblastoma, WHO 4 [24, 25]. This evidence concerns the gene IDH2 and glioblastoma.